Adds media to support DG44 cell lines and perfusion culture platforms for the commercialization of mAbs, recombinant proteins and other biotherapeutics.
The new facility adds capacity for the storage and handling of clinical trial supply materials at controlled room temperatures between 15 - 25 degrees Celsius.